Traitement de la maladie de surcharge lysosomaleMeilleures Entreprises
-
Pfizer Inc
-
Takeda Pharmaceutical Company Limited (Shire Plc)
-
Sanofi (Genzyme Corporation)
-
BioMarin
-
Johnson & Johnson (Actelion Pharmaceuticals Ltd)
*Avis de non-responsabilité : Les principales entreprises sont classées sans ordre particulier
![Marché du traitement de la maladie de surcharge lysosomale Major Players](https://s3.mordorintelligence.com/lysosomal-storage-disease-treatment-market/lysosomal-storage-disease-treatment-market_1678797705134_Picture2.webp)
Traitement de la maladie de surcharge lysosomaleConcentration du marché
![Traitement de la maladie de surcharge lysosomaleConcentration du marché](https://s3.mordorintelligence.com/lysosomal-storage-disease-treatment-market/lysosomal-storage-disease-treatment-market_1671192745164_Picture.webp)
Traitement de la maladie de surcharge lysosomaleListe des Entreprises
Pfizer Inc
Takeda Pharmaceutical Company Limited (Shire Plc)
Sanofi (Genzyme Corporation)
BioMarin
Johnson & Johnson (Actelion Pharmaceuticals Ltd)
Amicus Therapeutics, Inc
Alexion Pharmaceuticals, Inc
Sigilon Therapeutics, Inc
Orphazyme A/S